Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug emraclidine put to the test in healthy seniors

NCT ID NCT07219030

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times

Summary

This early-stage study is testing an experimental drug called emraclidine in healthy adults aged 65 and older. The main goals are to see how the drug moves through the body and to check for any side effects. About 40 participants will receive either the drug or a placebo. This research does not aim to treat any disease but to gather important safety information for future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Acpru /Id# 276996

    RECRUITING

    Grayslake, Illinois, 60030, United States

    Contact Phone: •••-•••-••••

  • Altasciences Clinical Los Angeles /ID# 276854

    RECRUITING

    Cypress, California, 90630, United States

  • Clinical Pharmacology Of Miami /ID# 276856

    RECRUITING

    Miami, Florida, 33172, United States

    Contact Phone: •••-•••-••••

  • K2 Medical Research, LLC /ID# 276636

    RECRUITING

    Maitland, Florida, 32751, United States

Conditions

Explore the condition pages connected to this study.